Significance of fetal hemoglobin-containing erythroblasts (F blasts) and the F blast/F cell ratio in myelodysplastic syndromes

Leukemia

Volumn 16, Issue 8, 2002, Pages 1478-1483

  Choi, J W ^a,b   Kim, Y ^a,c   Fujino, M ^d   Ito, M ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b Inha University School of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; F cell precursors; F cells; Myelodysplastic syndrome

Indexed keywords

GLYCOPHORIN C; HEMOGLOBIN F; PROTEIN ANTIBODY;

ACCURACY; ADULT; AGED; APOPTOSIS; ARTICLE; BONE MARROW EXAMINATION; CELL COUNT; CELL DEATH; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROCYTE; ERYTHROPOIESIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; STEM CELL; STRESS;

EID: 0036050016     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402536     Document Type: Article

References (31)

1. The postnatal decline of hemoglobin F synthesis in normal full-term infants
2. Fetal hemoglobin restriction to a few erythrocytes (F-cells) in normal human adults
3. F-cells in the adult: Normal values and levels in individuals with hereditary and acquired elevations of Hb F
4. Understanding fetal globin gene expression: A step towards effective HbF reactivation in haemoglobinopathies
5. HbF production in stressed erythropoiesis: Oobservations and kinetic models
6. HbF synthesis during stress erythropoiesis as determined by gamma-RNA/non-alpha-mRNA quantification
7. Hemoglobin F in myelodysplastic syndrome
8. Estimation of small percentage of foetal haemoglobin
9. Quantitation of HbF-chain types by HPLC in patients with myelodysplastic syndrome
10. High-performance liquid chromatographic separation of human haemoglobins: Simultaneous quantitation of foetal and glycated haemoglobins
11. Monoclonal antibody-based methods for quantitation of hemoglobin: Application to evaluating patients with sickle cell anemia treated with hydroxyurea
12. Detection of hemoglobin variants in erythrocytes by flow cytometry
13. Proposed flow cytometric reference method for the determination of erythroid F-cell counts
14. A new anti-hemoglobin F antibody against synthetic peptide for the detection of F-cell precursors (F-blasts) in bone marrow
15. Ineffective haematopoiesis and apoptosis in myelodysplastic syndromes
16. Extensive apoptosis of bone marrow cells as evaluated by the in situ end-labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes
17. Increased HbF levels in dyserythropoiesis
18. Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis
19. Studies on the diagnostic significance of hemoglobin F levels
20. Pediatric myelodysplasia: A study of 68 children and a new prognostic scoring system
21. Myelo-dysplastic syndrome with karyotype abnormality is associated with elevated F-cell production
22. Cytogenetic findings in 179 patients with myelodysplastic syndromes
23. Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: Apoptotic cells recovered from high-density fraction of bone marrow aspirates
24. Apoptosis in patients with myelodysplastic syndromes: Differential involvement of marrow cells in good vs poor prognosis patients and correlation with apoptosis-related genes
25. Apoptosis and its significance in MDS: Controversies revisited
26. Apoptotic index by Annexin V flow cytometry: Adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes
27. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes
28. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes
29. Is apoptosis a massive process in myelodysplastic syndromes?
30. Switch from fetal to adult hemoglobin is associated with a change in progenitor cell population
31. Myelodysplastic sydrome (MDS) associated with increased hemoglobin F and trisomy 8: Presentation of a patient